313TiPOpen-label phase II study of everolimus plus endocrine therapy in post-menopausal women with ER+, HER2- metastatic breast cancer (Chloe trial). (18th September 2017)

Record Type:: Journal Article
Title:: 313TiPOpen-label phase II study of everolimus plus endocrine therapy in post-menopausal women with ER+, HER2- metastatic breast cancer (Chloe trial). (18th September 2017)
Main Title:: 313TiPOpen-label phase II study of everolimus plus endocrine therapy in post-menopausal women with ER+, HER2- metastatic breast cancer (Chloe trial)
Authors:: Shien, T.
Shimomura, A.
Uemura, Y.
Kato, H.
Kitada, M.
Kikawa, Y.
Shiba, E.
Yoshida, T.
Morimoto, T.
Toyama, T.
Aihara, T.
Mukai, H.
Abstract:
Is Part Of:: Annals of oncology. Volume 28(2017)Supplement 5
Journal:: Annals of oncology
Issue:: Volume 28(2017)Supplement 5
Issue Display:: Volume 28, Issue 5 (2017)
Year:: 2017
Volume:: 28
Issue:: 5
Issue Sort Value:: 2017-0028-0005-0000
Page Start:
Page End:
Publication Date:: 2017-09-18
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdx365.076 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12574.xml